News Article
Live biotherapeutic products
12 October 2022
The Boom in Bacteria!
Candesic breaks down the newest potential addition to the blockbuster biologics market- live biotherapeutic products. Michelle Tempest and Isabel Brooks deep dive into how our body’s bacteria have inspired a new class of drug and investments for Pharma, PE and VC.
Thanks to Laing Buisson for publishing.
![](https://candesic.com/wp-content/uploads/2024/02/HealthcareMarketsUK_October_2022_copy-32-35_page-0001-1_page-0001.jpg)
![](https://candesic.com/wp-content/uploads/2024/02/HealthcareMarketsUK_October_2022_copy-32-35_page-0001-1_page-0002.jpg)
![](https://candesic.com/wp-content/uploads/2024/02/HealthcareMarketsUK_October_2022_copy-32-35_page-0001-1_page-0003.jpg)
![](https://candesic.com/wp-content/uploads/2024/02/HealthcareMarketsUK_October_2022_copy-32-35_page-0001-1_page-0004.jpg)